NCOA2 and Familial prostate cancer: Fancher et al., 2019 also report androgen receptor coactivators that have elevated expression in patients with prostate cancer, such as transcriptional intermediary factor 2 (TIF2), steroid receptor coactivator (SRC)-1, RAC3, p300, CBP, Tip60, and ARA70 [24].